For a better experience, click the Compatibility Mode icon above to turn off Compatibility Mode, which is only for viewing older websites.

Cancer is the second leading cause of death in the United States, claiming nearly 575,000 lives a year. Those deaths are the result of over 200 types of cancer, some of which remain only partially understood. But thanks to research, this gap between what we do and do not understand about cancer is shrinking.

We continue to take significant strides in how we treat cancer, and Drexel University College of Medicine is proud to contribute to that advancement by educating future researchers through our Cancer Biology (CBIO) program.

Drexel University College of Medicine's Cancer Biology program provides a master's degree focused on the fundamentals of cancer from an interdisciplinary perspective, including molecular and cell biology of cancer initiation, metastasis, treatment, and prevention. Graduates of the program gain comprehensive knowledge of molecular, cell, and cancer biology, as well as expertise in the latest techniques used in cancer biology research.

Is Cancer Biology for Me?

The Cancer Biology program is designed for students who wish to pursue a career in basic and applied cancer research, leading them to investigate the molecules, mechanisms, and pathways involved in the development of this disease.

Students in the program come from many backgrounds including:

  • New college graduates
  • Recent college graduates interested in career changes
  • Laboratory technicians
  • Industrial and biotechnology employees

 
Upcoming and Recent Events
 

Molecular & Cell Biology & Genetics/Cancer Biology Program Rotation Talks
   Thursday, May 26, 2016 at 1 p.m.
   New College Building, Biochemistry Library Room 11101, 245 North 15th Street | Video conference to QL C9

Speakers: MCBG and CB first-year graduate students

  • Chaitali Bhadiadra, MCBG Program
    Using cancer genomic databases to identify glycosyltransferases involved in cancer
    Advisor: Dr. Mauricio Reginato
  • Erica Dalla, CB Program
    Investigating the role of the chemokine receptor CX3CR1 in a preclinical model of metastatic inflammatory breast cancer
    Advisor: Dr. Olimpia Meucci
  • Leann Dudash, MCBG Program
    Combining rapamyacin treatment and methionine restriction increases autophagy in human cardiac fibroblasts
    Advisor: Dr. Chris Sell
  • Waleed Iqbal, CB Program
    Exogenous pyruvate facilitates cancer cell adaption to hypoxia
    Advisor: Dr. Nianli Sang
  • Dimpi Mukhopadhyay, CB Program
    Cloning full-length and individual domains of PPIE
    Advisor: Dr. Tara Davis
  • Kris Raghavan, MCBG Program
    Identifying stroma-derived exosomes in pancreatic cancer
    Advisor: Dr. Edna Cukierman

How to apply to the Cancer Biology program

 
Back to Top